GFGiuseppina Folesani

Giuseppina Folesani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Giuseppina Folesani has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Critical Issues in Assessing Occupational Exposure to Diesel Dust Exhaust

    by Giuseppina Folesani, Monica Gherardi, Maricla Galetti, Pier Giorgio Petronini, Fabrizio De Pasquale, Delia Cavallo, Massimo Corradi

    The Italian Interministerial Decree of February 11, 2021, introduces the diesel engine exhaust (DDE) among the carcinogenic occupational compounds, also establishing an occupational exposure limit. Elemental carbon (EC), improperly called black carbon, has been proposed as a tracer of DDE exposure; EC is the carbon that is quantified in the ambient matrixes after all the organic carbon has been removed; traditionally, EC is measured with a thermo-optical analytical technique. EC determination and relative interpretation are challenging for the following reasons: (i) the scarce availability of equipped laboratories hampers EC analysis, (ii) EC interpretation is not easy due to the lack of reference values. Finally, (iii) the limit value of 0.050 mg/m3 of EC in the workplace appears too high compared to recently published exposure data. All these aspects stimulate a reflection on the significance of EC data in the context of both occupational hygiene and occupational medicine.


  • Open Access

    Interaction between Occupational and Non-Occupational Arsenic Exposure and Tobacco Smoke on Lung Cancerogenesis: A Systematic Review

    by Giuseppina Folesani, Maricla Galetti, Pier Giorgio Petronini, Paola Mozzoni, Silvia La Monica, Delia Cavallo, Massimo Corradi

    Although a higher lung cancer risk has been already associated with arsenic exposure, the contribution of arsenic and its compounds to the carcinogenic effects of other agents, such as tobacco smoke, is not well characterized. This systematic review examined the relationship between occupational and non-occupational arsenic exposure and tobacco smoking on lung cancer risk using papers published from 2010 to 2022. Two databases, PUBMED and Scifinder, were used for the searches. Among the sixteen human studies included, four were about occupational exposure, and the others were about arsenic in drinking water. Furthermore, only three case-control studies and two cohort studies evaluated an additive or multiplicative interaction. The interaction between arsenic exposure and tobacco smoke seems to be negligible at low arsenic concentrations (<100 μg/L), while there is a synergistic effect at higher concentrations. Finally, it is not yet possible to assess whether a linear no-threshold (LNT) model for lung cancer risk can be applied to the co-exposure to arsenic and tobacco smoke. Although the methodological quality of the included studies is good, these findings suggest that rigorous and accurate prospective studies on this topic are highly needed.


  • Interaction between occupational radon exposure and tobacco smoke: a systematic review

    by Giuseppina Folesani, Maricla Galetti, Silvia Ranzieri, Pier Giorgio Petronini, Silvia La Monica, Massimo Corradi, Delia Cavallo

    This paper offers an updated overview on lung cancer risk due to occupational exposure to radon together with tobacco smoke habit. It evidences the quantitative role of smoking on radon exposure and discusses their interaction. The results show that smoking adjustments do not modify significantly lung cancer risk at both high and low radon concentrations.


  • The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25

    by Angela Guerra, Andrea Ticinesi, Franca Allegri, Antonio Nouvenne, Silvana Pinelli, Giuseppina Folesani, Fulvio Lauretani, Marcello Maggio, Loris Borghi, Tiziana Meschi

    Our aim was to compare the influence of maternal history of stones (MHS) and paternal history of stones (PHS) on composition of calculi and disease course in a group of patients with calcium nephrolithiasis (CN) aged between 15 and 25, the age range with the maximal influence of family history on disease expression. One-hundred thirty-five patients (68 F) with CN and one stone-forming parent were retrospectively selected from the database of our outpatient stone clinic, and categorized according to MHS or PHS. Data about stone disease course and composition of passed calculi, determined by chemical analysis or Fourier-transformed infrared spectrophotometry, were collected together with information on blood chemistry and 24-h urinary profile of lithogenic risk. The characteristics of disease course and stone composition were compared using logistic regression tests adjusted for age, sex, and BMI or analysis of covariance where appropriate. Patients with MHS (n = 46) had significantly higher urinary calcium/creatinine ratio and ammonium, a higher prevalence of urological treatments (57 vs 27 %, p < 0.001) and mixed calcium oxalate/calcium phosphate stone composition (69 vs 35 %, p = 0.002) than those with PHS. At multivariate logistic regression models, MHS was independently associated with urological treatments (OR 4.5, 95 %CI 1.9–10.7, p < 0.001) and the formation of calculi with mixed calcium oxalate/calcium phosphate composition (OR 5.8, 95 %CI 1.9–17.9, p = 0.002). The method of stone analysis did not affect this result. In conclusion, in subjects aged 15–25, MHS is associated with mixed calcium stones and with a higher risk for urological procedures, and should be, therefore, considered in the management of urolithiasis.


  • An investigation of multimorbidity measures as risk factors for pneumonia in elderly frail patients admitted to hospital

    by Andrea Ticinesi, Antonio Nouvenne, Giuseppina Folesani, Beatrice Prati, Ilaria Morelli, Loredana Guida, Fulvio Lauretani, Marcello Maggio, Tiziana Meschi


  • Open Access

    The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study

    by Antonio Nouvenne, Andrea Ticinesi, Giuseppina Folesani, Nicoletta Cerundolo, Beatrice Prati, Ilaria Morelli, Loredana Guida, Fulvio Lauretani, Marcello Maggio, Rosalia Aloe, et al.

    Serum procalcitonin and high-sensitivity C-reactive protein (hs-CRP) elevations have been associated with pneumonia in adults. Our aim was to establish their diagnostic usefulness in a cohort of hospitalized multimorbid patients ≥65 years old admitted to hospital with acute respiratory symptoms. With a retrospective cohort study design, all multimorbid patients ≥65 years-old with acute respiratory symptoms admitted to an internal medicine hospital ward in Italy from January to August 2013 were evaluated. Pneumonia diagnosis, comorbidities expressed through Cumulative Illness Rating Scale (CIRS), setting of living, length of stay, serum hs-CRP and procalcitonin at admission were collected for each patient. Data were analyzed with Mann-Whitney’s U test and multivariate Cox logistic regression analysis. A Receiver Operating Characteristic (ROC) curve was used to verify each biomarker’s association with pneumonia diagnosis. Four hundred fifty five patients (227 M) were included in the study, of whom 239 with pneumonia (138 M, mean age 80 ± 13) and 216 without pneumonia (89 M, mean age 80 ± 14). After adjustment for age and sex, median levels of hs-CRP were significantly higher in patients with pneumonia (116 mg/L, IQR 46.5–179.0, vs 22.5 mg/dl, IQR 6.9–84.4, p < 0.0001), while procalcitonin median levels were not (0.22 ng/ml IQR 0.12–0.87, vs 0.15 ng/ml, IQR 0.10–0.35, p = 0.08). The ROC analysis showed that, unlike procalcitonin, hs-CRP values were predictive of pneumonia (AUC 0.76, 95 % CI 0.72–0.79, p < 0.0001, cut-off value 61 mg/L), even after adjustment for possible confounders including nursing home residence and dementia. Serum hs-CRP levels >61 mg/L were independently associated with a 3.59-fold increased risk of pneumonia (OR 3.59, 95 % CI 2.35–5.48, p < 0.0001). In elderly multimorbid patients who require hospital admission for respiratory symptoms, serum hs-CRP testing seems to be more useful than procalcitonin for guiding the diagnostic process when clinical suspicion of pneumonia is present. Procalcitonin testing might hence be not recommended in this setting.


  • Idiopathic Calcium Nephrolithiasis and Hypovitaminosis D: A Case-control Study

    by Andrea Ticinesi, Antonio Nouvenne, Pietro Manuel Ferraro, Giuseppina Folesani, Fulvio Lauretani, Franca Allegri, Angela Guerra, Nicoletta Cerundolo, Rosalia Aloe, Giuseppe Lippi, et al.


  • Open Access

    Multimorbidity in elderly hospitalised patients and risk ofClostridium difficileinfection: a retrospective study with the Cumulative Illness Rating Scale (CIRS)

    by Andrea Ticinesi, Antonio Nouvenne, Giuseppina Folesani, Beatrice Prati, Ilaria Morelli, Loredana Guida, Francesca Turroni, Marco Ventura, Fulvio Lauretani, Marcello Maggio, et al.

    Objectives: To identify the role of chronic comorbidities, considered together in a literature-validated index (Cumulative Illness Rating Scale, CIRS), and antibiotic or proton-pump inhibitor (PPI) treatments as risk factors for hospital-acquiredClostridium difficileinfection (CDI) in elderly multimorbid hospitalised patients.Design: Retrospective cohort study.Setting: Subacute hospital geriatric care ward in Italy.Participants: 505 (238 male (M), 268 female (F)) elderly (age ≥65) multimorbid patients.Main outcome measures: The relationship between CDI and CIRS Comorbidity Score, number of comorbidities, antibiotic, antifungal and PPI treatments, and length of hospital stay was assessed through age-adjusted and sex-adjusted and multivariate logistic regression models. The CIRS Comorbidity Score was handled after categorisation in quartiles.Results: Mean age was 80.7±11.3 years. 43 patients (22 M, 21 F) developed CDI. The prevalence of CDI increased among quartiles of CIRS Comorbidity Score (3.9% first quartile vs 11.1% fourth quartile, age-adjusted and sex-adjusted p=0.03). In the multivariate logistic regression analysis, patients in the highest quartile of CIRS Comorbidity Score (≥17) carried a significantly higher risk of CDI (OR 5.07, 95% CI 1.28 to 20.14, p=0.02) than patients in the lowest quartile (<9). The only other variable significantly associated with CDI was antibiotic therapy (OR 2.62, 95% CI 1.21 to 5.66, p=0.01). PPI treatment was not associated with CDI.Conclusions: Multimorbidity, measured through CIRS Comorbidity Score, is independently associated with the risk of CDI in a population of elderly patients with prolonged hospital stay.


  • Family history influences clinical course of idiopathic calcium nephrolithiasis: case–control study of a large cohort of Italian patients

    by Angela Guerra, Giuseppina Folesani, Antonio Nouvenne, Andrea Ticinesi, Franca Allegri, Silvana Pinelli, Beatrice Prati, Ilaria Morelli, Loredana Guida, Rosalia Aloe, et al.

    To evaluate the contribution of family history of stones (FHS), up to second-degree relatives, on clinical course (age of first renal colic, bilateral disease, retained calculi, recurrences, urological procedures) of idiopathic calcium nephrolithiasis (ICN) and urinary parameters of lithogenic risk, a case–control study was carried out. Clinical records of 2080 patients with ICN were evaluated and categorized according to FHS. Data about clinical course of disease and urinary parameters of lithogenic risk were collected. Student’s t, Chi square tests and binary logistic regression were applied to discriminate groups with vs. without FHS. FHS was associated with an earlier onset of stone disease (age at first episode 32 ± 13 vs. 37 ± 15 years, p <0.001), particularly in females. After adjustment for multiple covariates, FHS was significantly associated to a higher risk of recurrence [odds ratio (OR) 1.2, 95 % confidence interval (1.1–1.4), p = 0.04], retained stones [OR 1.3, CI (1.1–1.5), p = 0.004], bilateral stones [OR 1.2, 95 % CI (1.1–1.5), p = 0.022] and urological procedures [OR 1.2, 95 % CI (1.1–1.5), p = 0.034]. FHS did not influence urinary parameters of lithogenic risk, except for calcium excretion in females. A positive family history influences the clinical course of ICN with some significant gender-related differences, substantially irrespective of urinary parameters of lithogenic risk.


  • Hippuric acid in 24 h urine collections as a biomarker of fruits and vegetables intake in kidney stone formers

    by Angela Guerra, Giuseppina Folesani, Pedro Mena, Andrea Ticinesi, Franca Allegri, Antonio Nouvenne, Silvana Pinelli, Daniele Del Rio, Loris Borghi, Tiziana Meschi

    This work aimed to underline the prospects of hippuric acid, a product of the metabolism of polyphenols, as a new biomarker of fruits and vegetables intake associated with lithogenic risk. Biochemical parameters of lithogenic risk and hippuric acid were measured in the 24 h urine collections of a cohort of 696 Italian kidney stone formers divided into two subgroups according to their different dietary habits. The link between lithogenic risk parameters and hippuric acid was assessed and this compound was revealed as a valuable biomarker of fruits and vegetables intake in kidney stone formers. A cut-off value of urinary excretion of hippuric acid, 300 mg/24 h, was set as the threshold of discrimination between low and high intake of fruits and vegetables for these patients. These results highlight the importance of monitoring of the excretion hippuric acid in urine to address proper dietary guidelines for the management of stone former patients.